Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus
Authors:
- Camila Moreno RosaCRCamila Moreno Rosa
- Dijon Henrique Salome CamposDCDijon Henrique Salome Campos
- David Rafael Abreu ReyesDRDavid Rafael Abreu Reyes
- Felipe Cesar DamattoFDFelipe Cesar Damatto
- Lucas Yamada KurosakiLKLucas Yamada Kurosaki
- Luana Urbano PaganLPLuana Urbano Pagan
- Mariana Janini GomesMGMariana Janini Gomes
- Camila Renata CorrêaCCCamila Renata Corrêa
- Ana Angelica Henrique FernandesAFAna Angelica Henrique Fernandes
- Marina Politi OkoshiMarina Politi Okoshi
- Katashi OkoshiKOKatashi Okoshi
Open Access
- 17 May 2022
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (5) , 982
Abstract
Clinical trials have shown that sodium glucose co-transporter 2 (SGLT2) inhibitors improve clinical outcomes in diabetes mellitus (DM) patients. As most studies were performed in Type 2 DM, the cardiovascular effects of SGLT2 inhibition still require clarification in Type 1 DM. We analyzed the effects of SGLT2 inhibitor dapagliflozin on cardiac remodeling in rats with streptozotocin-induced diabetes, an experimental model of Type 1 DM. Methods: Male Wistar rats were assigned into four groups: control (C, n = 14); control treated with dapagliflozin (C + DAPA, n = 14); diabetes (DM, n = 20); and diabetes treated with dapagliflozin (DM + DAPA, n = 20) for 8 weeks. Dapagliflozin dosage was 5 mg/kg/day. Statistical analyses: ANOVA and Tukey or Kruskal–Wallis and Dunn. Results: DM + DAPA presented decreased blood pressure and glycemia and increased body weight compared to DM (C 507 ± 52; C + DAPA 474 ± 50; DM 381 ± 52 *; DM + DAPA 430 ± 48 # g; * p < 0.05 vs. C; # p < 0.05 vs. C + DAPA and DM + DAPA). DM echocardiogram presented left ventricular and left atrium dilation with impaired systolic and diastolic function. Cardiac changes were attenuated by dapagliflozin. Myocardial hydroxyproline concentration and interstitial collagen fraction did not differ between groups. The expression of Type III collagen was lower in DM and DM + DAPA than their controls. Type I collagen expression and Type I-to-III collagen ratio were lower in DM + DAPA than C + DAPA. DM + DAPA had lower lipid hydroperoxide concentration (C 275 ± 42; C + DAPA 299 ± 50; DM 385 ± 54 *; DM + DAPA 304 ± 40 # nmol/g tissue; * p < 0.05 vs. C; # p < 0.05 vs. DM) and higher superoxide dismutase and glutathione peroxidase activity than DM. Advanced glycation end products did not differ between groups. Conclusion: Dapagliflozin is safe, increases body weight, decreases glycemia and oxidative stress, and attenuates cardiac remodeling in an experimental rat model of Type 1 diabetes mellitus.Keywords
Funding Information
- FAPESP (2015/02324-3, 2018/00567-4, 308557/2018-2, 310876/2018-4)
- CNPq (2015/02324-3, 2018/00567-4, 308557/2018-2, 310876/2018-4)
- UNESP (2015/02324-3, 2018/00567-4, 308557/2018-2, 310876/2018-4)
This publication has 69 references indexed in Scilit:
- Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive ratsCardiovascular Diabetology, 2013
- Aldosterone Blockade Reduces Mortality without Changing Cardiac Remodeling in Spontaneously Hypertensive RatsCellular Physiology and Biochemistry, 2013
- Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart diseaseFibrogenesis & Tissue Repair, 2012
- Advanced Glycation End Products and Diabetic Cardiovascular DiseaseCardiology in Review, 2012
- Loss of PPARγ expression by fibroblasts enhances dermal wound closureFibrogenesis & Tissue Repair, 2012
- Critical infarct size to induce ventricular remodeling, cardiac dysfunction and heart failure in ratsInternational Journal of Cardiology, 2011
- Myocardial Function during Chronic Food Restriction in Isolated Hypertrophied Cardiac MuscleThe American Journal of the Medical Sciences, 2000
- Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardiumDiabetologia, 1996
- Effect of metformin on glutathione and magnesium in normal and streptozotocin‐induced diabetic ratsJournal of Applied Toxicology, 1995
- Protection of the ischemic diabetic heart by L-propionylcarnitine therapyMolecular and Cellular Biochemistry, 1992